Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is a promising molecular diagnostics company with a strong product portfolio, including the game-changing Unity Complete, which has shown rapid revenue growth and a confident outlook. The company's QCT technology offers cost savings and they are expanding into the MRD space with the upcoming launch of UNITY Confirm, expected to generate significant revenue. With a solid market position and plans for future expansion, coupled with a strong performance in the market among other life sciences companies, BLLN is recommended as a buy with a potential price target of $160.

Bears say

BillionToOne is a molecular diagnostics company that offers a portfolio of ultrasensitive tests for prenatal genetic testing, cancer therapy selection, and response monitoring based on its Quantitative Counting Templates (QCT) molecular counting platform. However, the company faces several challenges, including limited market penetration, complex billing processes, and a potential weakening of its competitive position if it fails to protect its proprietary technology. Additionally, the company's revenue and profitability are dependent on government reimbursement and third-party payors, posing a risk to its financial outlook.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $125.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $125.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.